Diabetic renal disease in African Americans

被引:27
作者
Crook, ED
机构
[1] Wayne State Univ, Sch Med, Detroit, MI 48202 USA
[2] John D Dingell VA Med Ctr, Detroit, MI USA
关键词
African American; diabetic nephropathy; end-stage renal disease; hypertension; diabetes mellitus type 2;
D O I
10.1097/00000441-200202000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy (DN) is the No. I cause of end-stage renal disease in the United States and is highly prevalent in African Americans. Almost all DN in African Americans is caused by type 2 diabetes. Glycemic control and control of blood pressure are essential to prolong renal survival and to protect against cardiovascular events. Among African Americans, diabetic nephropathy seems to affect women more than men, which may be related to increased rates of obesity and diabetes in African American women. In addition to gender, the development of albuminuria, family history, and possibly birth weight are factors that predict progression of renal disease in African Americans with DN. The impact of glycemic control, appropriate antihypertensives, and the optimal level of blood pressure control in African Americans with advanced DN require further study. This article will review the clinical characteristics, risk factors, predictors of disease progression, and treatment of diabetic nephropathy in African Americans.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 59 条
  • [51] Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients
    Suthanthiran, R
    Khanna, A
    Cukran, D
    Adhikarla, R
    Sharma, VK
    Singh, T
    August, P
    [J]. KIDNEY INTERNATIONAL, 1998, 53 (03) : 639 - 644
  • [52] Does microalbuminuria predict diabetic nephropathy?
    Tabaei, BP
    Al-Kassab, AS
    Ilag, LL
    Zawacki, CM
    Herman, WH
    [J]. DIABETES CARE, 2001, 24 (09) : 1560 - 1566
  • [53] High prevalence of albuminuria among African-Americans with short duration of diabetes
    Thaler, LM
    El-Kebbi, IM
    Ziemer, DC
    Gallina, DL
    Dunbar, VG
    Phillips, LS
    [J]. DIABETES CARE, 1998, 21 (09) : 1576 - 1577
  • [54] RENAL-DISEASE IN HYPERTENSIVE ADULTS - EFFECT OF RACE AND TYPE-II DIABETES-MELLITUS
    TIERNEY, WM
    MCDONALD, CJ
    LUFT, FC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (06) : 485 - 493
  • [55] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853
  • [56] *US REN DAT SYS, 1999, USRDS 1999 ANN DAT R
  • [57] Yu HR, 1996, J AM SOC NEPHROL, V7, P2559
  • [58] Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease
    Yu, HR
    Bowden, DW
    Spray, BJ
    Rich, SS
    Freedman, BI
    [J]. HYPERTENSION, 1998, 31 (04) : 906 - 911
  • [59] 2000, LANCET, V255, P253